Tonix Pharmaceuticals Holding Corp.
(NASDAQ : TNXP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MNKMallinckrodt Plc
2.64%35.6121.1%$129.42m
PRGOPerrigo Co. Plc
1.55%74.096.7%$116.86m
SHPGShire PLC Sponsored ADR
0.48%171.240.4%$114.84m
ENDPEndo International Plc
2.69%16.068.9%$91.42m
JAZZJazz Pharmaceuticals Plc
0.43%174.552.2%$72.54m
ICPTIntercept Pharmaceuticals, Inc.
0.40%103.8318.7%$68.90m
SAGESAGE Therapeutics, Inc.
-1.90%149.209.6%$56.08m
UTHRUnited Therapeutics Corporation
-0.37%125.1514.4%$50.37m
CTLTCatalent Inc
0.39%41.092.6%$48.00m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.09%133.226.8%$42.32m
SUPNSupernus Pharmaceuticals, Inc.
-0.09%44.766.2%$40.18m
PTLAPortola Pharmaceuticals, Inc.
-1.60%25.187.7%$39.89m
ICLRICON Plc
-0.97%142.294.2%$39.60m
ZGNXZogenix, Inc.
-4.53%46.4011.9%$35.75m
HZNPHorizon Pharma plc
0.24%20.627.5%$32.82m

Company Profile

Tonix Pharmaceuticals Holding Corp. operates as a clinical-stage pharmaceutical company, which engages in the development of pharmaceutical products for public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It offers TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.